PDL BioPharma Story

PDLI -- USA Stock  

USD 3.11  0.05  1.58%

Macroaxis does not monitor all media channels or aggregates social signals for PDL BioPharma. But even though we do not provide professional-grade financial sentiment analysis on PDL BioPharma, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for PDL BioPharma. Additionally take a look at PDL BioPharma Hype Analysis, PDL BioPharma Correlation and PDL BioPharma Performance.
Taking Tally Of The New York Times Company , PDL BioPharma, Inc.
The shares of The New York Times Company have increased by more than 33.46 percent this year alone. The shares recently went down by -4.83 percent or -0.9 and now trades at 17.75. The Dirty Secret to Trading PDL BioPharma, Inc. , The New York Times ... - USA Commerce Daily

Read More...   

Story Momentum

This media report from stocknewsgazette.com distributed on December 8, 2017 was a factor to the next trading day price appreciation.The trading delta at closing time against the next closing price was 1.75% . The trading delta at closing time when the story was published against the current closing price is 11.23% .

Similar stores for PDL BioPharma

few hours ago at www.fairfieldcurrent.com 
JPMorgan Chase Co. Has 669,000 Stake in PDL BioPharma Inc - Fairfield Current
news
JPMorgan Chase Co. Has 669,000 Stake in PDL BioPharma Inc Fairfield CurrentIs PDL Biopharma Inc Going to Burn These Institutional Investors Thorold News Thorold NewsPDL Biopharma Inc Big Money Quarterly Sentiment at 0.76 K ReviewerWest Oak Capital Has Raised Emerson Electric Co Stake Vanguard Group Has Cut Its Pdl Biopharma Stake The FinReviewerView full coverage on Google News
few days ago at thewellesleysnews.com 
Analyst Opinion Summary PDL BioPharma, Inc. , Lions Gate Entertainment Corp. - Analyst Journal
news
Analyst Opinion Summary PDL BioPharma, Inc. , Lions Gate Entertainment Corp. Analyst JournalPDL BioPharma, Inc. tinted gains of 0.31 percent to US3.19. The volume of 1.5 Million shares climbed down over an trading activity ...
over a week ago at finexaminer.com 
PDL BioPharma, Inc. At 3.02 Forms Bottom Pennymac Mortgage Investment Trust s Sentiment Is 0.97 - The FinExami...
news
PDL BioPharma, Inc. At 3.02 Forms Bottom Pennymac Mortgage Investment Trust s Sentiment Is 0.97 The FinExaminerPDL BioPharma, Inc. formed multiple bottom with 2.78 target or 8.00 percent below todays 3.02 share price. PDL BioPharma, Inc. has 440.85M ...
over two weeks ago at flecha123.com 
PDL Biopharma Inc Institutional Investor Sentiment Trend - Flecha 123
news
PDL Biopharma Inc Institutional Investor Sentiment Trend Flecha 123Current Variation PDL BioPharma, Inc., Nyse Nasdaq NewsRenaissance Technologies LLC Has 24.13 Million Holdings in PDL BioPharma Inc Fairfield CurrentAt 2.77 PDL BioPharma, Inc. Forms Multiple Bottom Pattern The EN BulletinPDL Biopharma Incs Sentiment is 0.76 Thorold NewsView full coverage on Google News
over two weeks ago at nysenasdaqnews.com 
Stocks Roundup PDL BioPharma, Inc., - Nyse Nasdaq News
nasdaq News
Stocks Roundup PDL BioPharma, Inc., Nyse Nasdaq NewsNotable Technical and Performance analysis of the PDL BioPharma, Inc. stocks which belongs to US stocks Exchanges ...
over three weeks ago at nysenasdaqnews.com 
Is It Time To Hold Stock PDL BioPharma, Inc., - Nyse Nasdaq News
nasdaq News
Is It Time To Hold Stock PDL BioPharma, Inc., Nyse Nasdaq NewsMay Be The Best In A Crowed Market PDL BioPharma, Inc. MONReportHeres What Long-Term Traders Should Know PDL BioPharma, Inc., , Amicus Therapeutics, Inc., Global Export LinesView full coverage on Google News
over a month ago at kreviewer.com 
PDL BioPharma, Inc. Trading at 2.92 Forms Multiple Bottom Pattern - K Reviewer
news
PDL BioPharma, Inc. Trading at 2.92 Forms Multiple Bottom Pattern K ReviewerBig Money Sentiment increased to 0.76 in 2018 Q3. It has change of 0.13, from 2018Q2s 0.63. The ratio improved due to PDL BioPharma, Inc. positioning 17 ...
over a month ago at www.thecoinguild.com 
Stock Watch Investors Keen on Shares of PDL BioPharma, Inc. as it Makes Headlines With Moves - The Coin Guild
news
Stock Watch Investors Keen on Shares of PDL BioPharma, Inc. as it Makes Headlines With Moves The Coin GuildPDL Biopharma Inc Q3 2018 Sentiment Reported At 0.76 The EN BulletinPDL Biopharma Inc Big Money Positioning Change, Sentiment at 0.76 Z TribunePDL BioPharma Inc Shares Sold by Russell Investments Group Ltd. PressOracleView full coverage on Google News
over a month ago at stocknewsgazette.com 
Set Sail With Builders FirstSource, Inc. , PDL BioPharma, Inc. - StockNewsGazette
news
Set Sail With Builders FirstSource, Inc. , PDL BioPharma, Inc. StockNewsGazetteThe shares of Builders FirstSource, Inc. have decreased by more than -43.80 percent this year alone. The shares recently went down by -14.25 percent or -2.04 and now ...
over a month ago at nasdaqclick.com 
Noticeable Analysts ideas PDL BioPharma, Inc. - Nasdaq Click
nasdaq News
Noticeable Analysts ideas PDL BioPharma, Inc. Nasdaq ClickPDL BioPharma, Inc. s Stock Price Update PDL BioPharma, Inc. stock price ended its day with gain 2.33 percent and finalized at the price of 3.07, ...
over a month ago at www.fairfieldcurrent.com 
PDL BioPharma Inc Shares Bought by Systematic Financial Management LP - Fairfield Current
news
PDL BioPharma Inc Shares Bought by Systematic Financial Management LP Fairfield CurrentSystematic Financial Management LP grew its holdings in shares of PDL BioPharma Inc by 21.7 percent during the third quarter, according to its most ...
over three months ago at www.finbulletin.com 
Soaring beliefs Legg Mason, Inc. , PDL BioPharma, Inc.
news
FinBulletinFull coverage
over three months ago at enbulletin.com 
Holder Schwab Charles Investment Management Has Lifted Pdl Biopharma Holding As Servicenow NOW ...
news
The EN BulletinFull coverage

Debt to Equity

Debt to Equity Comparative Analysis

  Debt to Equity 
      PDL BioPharma Comparables 
PDL BioPharma is currently under evaluation in debt to equity category among related companies. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Additionally take a look at PDL BioPharma Hype Analysis, PDL BioPharma Correlation and PDL BioPharma Performance. Please also try Headlines Timeline module to stay connected to all market stories and filter out noise. drill down to analyze hype elasticity.
Search macroaxis.com